Vimarsana
Biggest News Aggregation in the World

Page 35 - Multiple Sclerosis Ms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Ms Today - Breaking & Trending Today

Possible Benefits of Calorie Restriction in Multiple Sclerosis - Vimarsana News

Possible Benefits of Calorie Restriction in Multiple Sclerosis

Changes in specific types of glycerophospholipids may contribute to reduced memory T cell subsets that are observed in people with multiple sclerosis on intermittent calorie restriction.

Epstein-Barr Virus a Likely Leading Cause of Multiple Sclerosis - Vimarsana News

Epstein-Barr Virus a Likely Leading Cause of Multiple Sclerosis

Epstein-Barr virus is the likely cause of multiple sclerosis, new research confirms. Investigators found the risk of MS increased 32-fold following EBV infection.

Half an Hour of Daily Sun Exposure Cuts MS Risk in Half - Vimarsana News

Half an Hour of Daily Sun Exposure Cuts MS Risk in Half

Whereas previous research suggests sunlight can be protective against MS development, a new study shows even half an hour of daily sun exposure risk cuts MS risk in half in children and young adults.

Rituximab Trumps Natalizumab in MS Relapse - Vimarsana News

Rituximab Trumps Natalizumab in MS Relapse

Although rituximab was consistently linked to better relapse outcomes vs natalizumab in new research, outcomes did not differ between dimethyl fumarate and fingolimod.

B-Cell Repletion Common With MS Drug, but No Symptom Worsening - Vimarsana News

B-Cell Repletion Common With MS Drug, but No Symptom Worsening

Although some repletion of B cells occurs with the B-cell depleting MS drug ocrelizumab, the effect does not appear to be associated with symptom worsening or a 'wearing off' effect.